J Gen Intern Med 24(1):129131 Kamata Y, Takano K, Kishihara E, Watanabe M, Ichikawa R, Shichiri M (2017) Distinct clinical characteristics and therapeutic modalities for diabetic ketoacidosis in type 1 and type 2 diabetes mellitus
R.LeichnerT
No large-scale pharmaceutical operation operates without occasional regulatory findings
The launch of TrumpRx will further extend patients reach to Ozempic and Wegovy, including the newly approved Wegovy pill, Novo said in a statement, via the Financial Times
In brief, first-generation NPs nonspecifically targets tumor cells, second-generation focuses on active targeting through incorporation of ligands and specific antigens at NPs surfaces and third generation provides a multi-stage strategy best matching therapy and diagnostic (theranostic) purposes
I know that advice is only useful if it is actually doable